secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001628280-25-012616
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp reports Q4 revenue up 14%, 2025 guidance for lower EBITDA
------------------------------------------------------------------------

- Q4 revenue from continuing operations $14.4M (+14% YoY); net income $986k vs loss $10.2M.
- System-wide sales $145.2M (+9% Q4), comp sales 6%. Full-year sales $530.3M (+9%).
- 2025 guidance: system-wide sales $550-570M, consolidated adj EBITDA $10-11.5M vs $11.4M in 2024.
- New franchised clinic openings expected 30-40 in 2025 vs 57 in 2024; refranchising of corp clinics ongoing.
- Comp plan amended: CEO STIP max up to 125% base salary if EBITDA exceeds budget; CFO up to 62.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000162828025012616/0001628280-25-012616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000162828025012616/jynt-20250313.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-012616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer